950848-60-9

Basic information

• Product Name: C₂₃H₃₅BrN₄O₄
• Synonyms: C₂₃H₃₅BrN₄O₄
• CAS NO: 950848-60-9
• Molecular Weight: 511.459
• Mol File: 950848-60-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₃H₃₅BrN₄O₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₃H₃₅BrN₄O₄(950848-60-9)
• EPA Substance Registry System: C₂₃H₃₅BrN₄O₄(950848-60-9)

Safety Data

• Hazardous Substances Data: 950848-60-9(Hazardous Substances Data)

Upstream product

• 950848-59-6 C₁₃H₁₈BrN₃O₂ 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Relevant articles and documents

HETEROCYCLIC SUBSTITUTED PIPERAZINE COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY

The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: Chemical formula should be inserted here as it appears on the abstract in paper form. or a pharmaceutically acceptable salt, solvate or ester thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non limiting example(s) include, psoriasis), autoimmune diseases (non limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non limiting example(s) include, allograft rejection, zenograft rejection), infectious diseases (e.g , tuberculoid leprosy), fixed drug eruptions, cutaneous delayed type hypersensitivity responses, ophthalmic inflammation, type I diabetes, viral meningitis and tumors using a compound of Formula 1.